Ash A. Alizadeh

ScholarGPS® ID: 10968355573713

Highly Ranked Scholar - Lifetime:

Circulating tumor DNA

Show Less

Affiliation

Stanford University, Stanford, United States

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

232

Predicted Citations

46,567

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
ViPOR’s Venom — Rationally Targeting DLBCL with Precision (journal article) Goldstein, Jordan S. \| Alizadeh, Ash A. New England Journal of Medicine, volume 390, issue 23, pages 2209-2211 (2024). 10.1056/NEJMe2405437 Cite \| Source
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy (journal article) Hamilton, Mark P. \| Sugio, Takeshi \| Noordenbos, Troy \| Shi, Shuyu \| Bulterys, Philip L. \| Liu, Chih Long \| Kang, Xiaoman \| Olsen, Mari N. \| Good, Zinaida \| Dahiya, Saurabh \| ... \| Miklos, David B. New England Journal of Medicine, volume 390, issue 22, pages 2047-2060 (2024). 10.1056/NEJMoa2401361 Cited by (2) \| Cite \| Source
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment (journal article) Kastenschmidt, Jenna M. \| Schroers-Martin, Joseph G. \| Sworder, Brian J. \| Sureshchandra, Suhas \| Khodadoust, Michael S. \| Liu, Chih Long \| Olsen, Mari \| Kurtz, David M. \| Diehn, Maximilian \| Wagar, Lisa E. \| Alizadeh, Ash A. Cell Stem Cell, volume 31, issue 3, pages 410-420.e4 (2024). 10.1016/j.stem.2024.01.012 Cited by (5) \| Cite \| Source
Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas (journal article) Shukla, Navika D. \| Schroers-Martin, Joseph G. \| Sworder, Brian J. \| Kathuria, Karan Raj \| Alig, Stefan K. \| Frank, Matthew J. \| Miklos, David B. \| Coutre, Steven \| Diehn, Maximilian \| Khodadoust, Michael S. \| ... \| Alizadeh, Ash A. Blood Advances, volume 8, issue 3, pages 780-784 (2024). 10.1182/bloodadvances.2023011997 Cite \| Source
Absence of Evidence for Pervasive CAR19 Driven T-Cell Lymphomagenesis Revealed By Comprehensive Genomic Profiling of an Index Tumor. (journal article) Hamilton, Mark P. \| Sugio, Takeshi \| Noordenbos, Troy \| Shi, Shuyu \| Diehn, Max \| Gratzinger, Dita \| Miklos, David B. \| Alizadeh, Ash A. \| Good, Zinaida Transplantation and Cellular Therapy, volume 30, issue 2, pages S487-S488 (2024). 10.1016/j.jtct.2024.02.009 Cited by (1) \| Cite \| Source
A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis (journal article) Shree, Tanaya \| Haebe, Sarah \| Czerwinski, Debra K. \| Eckhert, Erik \| Day, Grady \| Sathe, Anuja \| Grimes, Susan \| Frank, Matthew J. \| Maeda, Lauren S. \| Alizadeh, Ash A. \| ... \| Levy, Ronald Blood Advances, volume 8, issue 1, pages 130-142 (2024). 10.1182/bloodadvances.2023011589 Cite \| Source
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma (journal article) Johansson, Patricia \| Alig, Stefan \| Richter, Julia \| Hanoun, Christine \| Rekowski, Jan \| Dürig, Jan \| Ylstra, Bauke \| de Jong, Daphne \| Klapper, Wolfram \| Alizadeh, Ash A. \| ... \| Hüttmann, Andreas Annals of Hematology, volume 102, issue 12, pages 3445-3455 (2023). 10.1007/s00277-023-05393-1 Cited by (2) \| Cite \| Source
Investigating the Cell States and Prognostic Impact of Tumor Microenvironment Ecosystems in Classic Hodgkin Lymphoma (journal article) Su, Shengqin \| Subramanian, Ajay \| Flerlage, Timothy \| Flerlage, Jamie E. \| Alig, Stefan K. \| Moding, Everett J. \| Hoppe, Richard T. \| Advani, Ranjana H. \| Natkunam, Yasodha \| Alizadeh, Ash A. \| Binkley, Michael S. Blood, volume 142, issue Supplement 1, pages 3016-3016 (2023). 10.1182/blood-2023-180288 Cite \| Source
Distinct Circulating Genomic Features of Classical Hodgkin Lymphoma of Older Adults (journal article) Rossi, Cédric \| Boegeholz, Jan \| Alig, Stefan K. \| Garofalo, Andrea \| Shahrokh Esfahani, Mohammad \| Schroers-Martin, Joseph \| Olsen, Mari \| Kang, Xiaoman \| Kurtz, David M. \| Sugio, Takeshi \| ... \| Alizadeh, Ash A. Blood, volume 142, issue Supplement 1, pages 4369-4369 (2023). 10.1182/blood-2023-178257 Cite \| Source
Early and Sustained Circulating Tumor DNA Response Dynamics after Loncastuximab Tesirine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (journal article) Kurtz, David M. \| Hogan, Gregory \| Schultz, Andre \| Chabon, Jacob J. \| Alizadeh, Ash A. \| Havenith, Karin \| Samari, Sara \| Kopotsha, Tim \| Wang, Luqiang \| Qin, Yajuan \| ... \| Pantano, Serafino Blood, volume 142, issue Supplement 1, pages 3133-3133 (2023). 10.1182/blood-2023-179977 Cite \| Source
Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study (journal article) Sworder, Brian J. \| Yoon, Sang Eun \| Kim, Seok Jin \| Schultz, Andre \| Hogan, Gregory \| Close, Sandra \| Chabon, Jacob J. \| Diehn, Maximilian \| Kurtz, David M. \| Alizadeh, Ash A. \| Kim, Won Seog Blood, volume 142, issue Supplement 1, pages 69-69 (2023). 10.1182/blood-2023-187650 Cite \| Source
Phased Variants Allow Robust Profiling of Circulating Tumor DNA in Untreated Follicular Lymphomas (journal article) Nagy, Ákos \| Bátai, Bence \| Hogan, Gregory \| Chabon, Jacob J. \| Troke, Mikayla \| Riley, Lance \| Schultz, Andre \| Close, Sandra \| Diehn, Maximilian \| Alpár, Donát \| ... \| Bödör, Csaba Blood, volume 142, issue Supplement 1, pages 1626-1626 (2023). 10.1182/blood-2023-189824 Cite \| Source
Inferred Gene Expression By Cell-Free DNA Profiling Allows Noninvasive Lymphoma Classification (journal article) Mutter, Jurik A \| Shahrokh Esfahani, Mohammad \| Schroers-Martin, Joseph \| Alig, Stefan K. \| Hamilton, Mark P. \| Sworder, Brian J. \| Tessoulin, Benoit \| Boegeholz, Jan \| Flerlage, Timothy \| Flerlage, Jamie E. \| ... \| Alizadeh, Ash A. Blood, volume 142, issue Supplement 1, pages 245-245 (2023). 10.1182/blood-2023-186853 Cite \| Source
End-of-Treatment Response Assessment after Frontline Therapy for Aggressive B-Cell Lymphoma: Landmark Comparison of a Singular PET/CT Scan Versus Ultrasensitive Circulating Tumor DNA (journal article) Roschewski, Mark \| Lindenberg, Liza \| Mena, Esther \| Lakhotia, Rahul \| Melani, Christopher \| Steinberg, Seth M. \| Schultz, Andre \| Hogan, Gregory \| Chabon, Jake J. \| Close, Sandra \| ... \| Wilson, Wyndham H. Blood, volume 142, issue Supplement 1, pages 192-192 (2023). 10.1182/blood-2023-180007 Cited by (1) \| Cite \| Source
An Integrated Multimodal Framework for Noninvasive TCL Disease Detection and Monitoring (journal article) Sugio, Takeshi \| Shukla, Navika \| Khodadoust, Michael S \| Nesselbush, Monica \| Kato, Koji \| Alig, Stefan K. \| Boegeholz, Jan \| Schroers-Martin, Joseph \| Shahrokh Esfahani, Mohammad \| Mutter, Jurik A. \| ... \| Alizadeh, Ash A. Blood, volume 142, issue Supplement 1, pages 1620-1620 (2023). 10.1182/blood-2023-180492 Cite \| Source
Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma (journal article) Schroers-Martin, Joseph \| Mutter, Jurik A \| Shahrokh Esfahani, Mohammad \| Scherer, Florian \| Soo, Joanne \| Alig, Stefan K. \| Kurtz, David M. \| Sugio, Takeshi \| Rossi, Cédric \| Tessoulin, Benoit \| ... \| Alizadeh, Ash A. Blood, volume 142, issue Supplement 1, pages 528-528 (2023). 10.1182/blood-2023-187116 Cite \| Source
Circulating Tumor DNA Dynamics as Early Outcome Predictors for Lisocabtagene Maraleucel as Second-Line Therapy for Large B-Cell Lymphoma from the Phase 3 TRANSFORM Study (journal article) Stepan, Lara \| Ansari, Sahar \| Okal, Abood \| Dell'Aringa, Justine \| Thompson, Ethan \| Crotta, Alessandro \| Chow, Victor A \| Abramson, Jeremy S. \| Kamdar, Manali \| Chabon, Jacob J. \| ... \| Peiser, Leanne Blood, volume 142, issue Supplement 1, pages 225-225 (2023). 10.1182/blood-2023-181007 Cited by (1) \| Cite \| Source
Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy (journal article) Goldstein, Jordan \| Kim, Won Seog \| Yoon, Sang Eun \| Kim, Seok Jin \| Roschewski, Mark \| Westin, Jason \| Lynch, Ryan C \| Alig, Stefan K. \| Close, Sandra \| Chabon, Jacob J. \| ... \| Kurtz, David M. Blood, volume 142, issue Supplement 1, pages 187-187 (2023). 10.1182/blood-2023-187759 Cited by (1) \| Cite \| Source
Identification and confirmation via in situ hybridization of Merkel cell polyomavirus in rare cases of posttransplant cutaneous T‐cell lymphoma (journal article) Lawrence, Lauren \| Wang, Aihui \| Charville, Gregory \| Liu, Chih Long \| Garofalo, Andrea \| Alizadeh, Ash \| Jangam, Diwash \| Pinsky, Benjamin A. \| Sahoo, Malaya \| Gratzinger, Dita \| ... \| Stehr, Henning Journal of Cutaneous Pathology, volume 50, issue 9, pages 835-844 (2023). 10.1111/cup.14486 Cite \| Source
Cell-of-Origin Subtypes and Therapeutic Benefit from Polatuzumab Vedotin (journal article) Palmer, Adam C. \| Kurtz, David M. \| Alizadeh, Ash A. New England Journal of Medicine, volume 389, issue 8, pages 764-766 (2023). 10.1056/NEJMc2306105 Cited by (10) \| Cite \| Source

Title	Investigators	Year	Cost	Agency
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation	Alizadeh, Ash Arash \| Khush, Kiran Kaur	2020	$606,977	NATIONAL CANCER INSTITUTE
A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy	Alizadeh, Ash Arash \| Diehn, Maximilian	2020	$561,946	NATIONAL CANCER INSTITUTE
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer	Alizadeh, Ash Arash \| Diehn, Maximilian \| Liao, Joseph C	2020	$625,866	NATIONAL CANCER INSTITUTE
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer	Alizadeh, Ash Arash \| Diehn, Maximilian	2020	$641,101	NATIONAL CANCER INSTITUTE
Noninvasive monitoring of lung cancer patients treated with radiotherapy	Alizadeh, Ash Arash \| Diehn, Maximilian	2019	$356,081	NATIONAL CANCER INSTITUTE
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma	Alizadeh, Ash Arash \| Davis, Mark Morris \| Levy, Ronald	2019	$604,097	NATIONAL CANCER INSTITUTE
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation	Alizadeh, Ash Arash \| Khush, Kiran Kaur	2019	$617,410	NATIONAL CANCER INSTITUTE
A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy	Alizadeh, Ash Arash \| Diehn, Maximilian	2019	$561,946	NATIONAL CANCER INSTITUTE
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma	Alizadeh, Ash Arash \| Davis, Mark Morris \| Elias, Joshua E \| Levy, Ronald	2018	$632,932	NATIONAL CANCER INSTITUTE
Noninvasive monitoring of lung cancer patients treated with radiotherapy	Alizadeh, Ash Arash \| Diehn, Maximilian	2018	$367,095	NATIONAL CANCER INSTITUTE
Noninvasive monitoring of lung cancer patients treated with radiotherapy	Alizadeh, Ash Arash \| Diehn, Maximilian	2017	$367,095	NATIONAL CANCER INSTITUTE
Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma	Alizadeh, Ash Arash \| Davis, Mark Morris \| Elias, Joshua E \| Levy, Ronald	2017	$643,804	NATIONAL CANCER INSTITUTE
Noninvasive monitoring of lung cancer patients treated with radiotherapy	Alizadeh, Arash Ash \| Diehn, MAXIMILIAN (contact)	2016	$372,645	NATIONAL CANCER INSTITUTE
Noninvasive monitoring of lung cancer patients treated with radiotherapy	Alizadeh, Arash Ash \| Diehn, MAXIMILIAN (contact)	2015	$376,669	NATIONAL CANCER INSTITUTE